Research Topic

Cannabidiol Treatment in Neurotherapeutic Interventions

About this Research Topic

Touted as a cure-all for many health conditions and disorders (e.g., anxiety, depression, schizophrenia, PTSD), cannabidiol (i.e. CBD) has become increasingly ubiquitous in the marketplace. It is important to note that, unlike tetrahydrocannabinol (i.e. THC, the main psychoactive chemical in cannabis), CBD is ...

Touted as a cure-all for many health conditions and disorders (e.g., anxiety, depression, schizophrenia, PTSD), cannabidiol (i.e. CBD) has become increasingly ubiquitous in the marketplace. It is important to note that, unlike tetrahydrocannabinol (i.e. THC, the main psychoactive chemical in cannabis), CBD is non-addictive, which makes it an exceptional alternative to THC-derivative cannabinoid drugs. Spurred by the increasing legality of the medical use of the Cannabis sativa plant, a number of medical benefits of CBD have been reported. In the U.S. specifically, CBD (Epidiolex®) is currently marketed for the treatment of Dravet and Lennox-Gastaut syndromes, pediatric epilepsies resistant to anticonvulsants, as well as for spasticity in multiple sclerosis (Sativex®, THC:CBD). Emerging evidence from basic and clinical research suggests a relevant role for CBD in treating a variety of neuropsychiatric disorders, including schizophrenia, depression, PTSD, and drug addiction. However, very little is known regarding the precise neurobiological mechanisms, pharmacokinetics, drug interactions, and clinical consequences of CBD treatment in many of these clinical conditions.

Despite the current CBD “boom” in commercially available products, often at the edge of the law, it remains to be investigated if CBD is an effective medical treatment for a wide range of neuropsychiatric conditions. The aim of this Research Topic is to bring together international experts in the areas of psychiatry, pharmacology, psychology, and neuroscience to provide a deep overview and analysis of scientifically sound evidence that evaluates the use of CBD alone or associated with another drug as a new therapeutic tool for the treatment of neuropsychiatric disorders. All types of articles reporting basic, translational, experimental, or clinical research that includes the most recent and relevant findings in the field of CBD neurotherapeutics are welcome.


Keywords: : Cannabidiol, CBD, therapeutic, neuroscience, neurology, pharmacology, psychology


Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.

Recent Articles

Loading..

About Frontiers Research Topics

With their unique mixes of varied contributions from Original Research to Review Articles, Research Topics unify the most influential researchers, the latest key findings and historical advances in a hot research area! Find out more on how to host your own Frontiers Research Topic or contribute to one as an author.

Topic Editors

Loading..

Submission Deadlines

18 July 2020 Manuscript
16 October 2020 Manuscript Extension

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..

Topic Editors

Loading..

Submission Deadlines

18 July 2020 Manuscript
16 October 2020 Manuscript Extension

Participating Journals

Manuscripts can be submitted to this Research Topic via the following journals:

Loading..
Loading..

total views article views article downloads topic views

}
 
Top countries
Top referring sites
Loading..